Ünal Metin Tokat

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

Özge Saatci, Aysegül Kaymak, Umar Raza et al. · Nature Communications · 2020 · 364 citations · Full text

Medicine, Cancer Biology, Oncology +17

Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer

Rasmi R. Mishra, Nevin Belder, Suhail A. Ansari et al. · Clinical Cancer Research · 2018 · 66 citations · Full text

Medicine, Oncology, Pharmacology +16

Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer

Ridho Assidicky, Ünal Metin Tokat, Ibrahim Oğuzhan Tarman et al. · Breast Cancer Research and Treatment · 2022 · 61 citations · Full text

Medicine, Cancer Biology, Oncology +14

TLR ligand loaded exosome mediated immunotherapy of established mammary Tumor in mice

Tugce Canavar Yildirim, Nilsu Turay, Tugce Bildik et al. · Immunology Letters · 2021 · 35 citations

Medicine, Immunology, Oncology +14

Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer

Özge Saatci, Rashedul Alam, Kim‐Tuyen Huynh‐Dam et al. · Cell Death and Disease · 2024 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17